Acorda Therapeutics, Inc. (NQ: ACOR)
34.62 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 8:10 PM EDT, Apr 17, 2014  /  Add to My Watchlist      
(ACOR) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
April 20, 2014
(Stock Blog Hub, 7/26/13)
Acorda Therapeutics, Inc. (ACOR) recently announced that an additional method of use patent (US patent application no. 8,440,703) related to Ampyra twice-daily dosing...(read more)
(Samurai Trader, 4/15/13)
On a day when the carnage was broad based, it was easy to find the stocks that were not getting killed. The trouble was, most of the early winners had reversals during the day and gave everything back. One of the few...(read more)
(Stock Blog Hub, 10/6/11)
•    Monsanto Co. (NYSE:MON) reported its fiscal fourth-quarter loss of $0.22 cents a share, better than the Zacks Consensus Estimate of a loss of $0.27. Revenues rose...(read more)
Acorda Therapeutics (ACOR) Company Overview

There is no analysis for ACOR yet. But you can go to Wikinvest to help create one!


Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here